+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Agricultural Biotechnology - Global Market Trajectory & Analytics

  • ID: 338408
  • Report
  • April 2021
  • Region: Global
  • 211 Pages
  • Global Industry Analysts, Inc
Global Agricultural Biotechnology Market to Reach $66.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Agricultural Biotechnology estimated at US$35.3 Billion in the year 2020, is projected to reach a revised size of US$66.2 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027. Molecular Diagnostics, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$26.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue Culture segment is readjusted to a revised 10.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $10.5 Billion, While China is Forecast to Grow at 8.7% CAGR

The Agricultural Biotechnology market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.4 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.7% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Vaccines Segment to Record 8.5% CAGR

In the global Vaccines segment, USA, Canada, Japan, China and Europe will drive the 8.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.2 Billion in the year 2020 will reach a projected size of US$5.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.6 Billion by the year 2027.

Select Competitors (Total 70 Featured):
  • ADAMA Agricultural Solutions Ltd.
  • BASF SE
  • Bayer CropScience AG
  • Certis USA LLC
  • Dow AgroSciences LLC
  • DuPont Pioneer
  • Marrone Bio Innovations Inc.
  • Monsanto Company
  • Performance Plants Inc.
  • Syngenta AG
  • Valent BioSciences Corporation
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Prelude
  • Recent Market Activity
  • Widening Gap between Food Demand and Production Raises Significance of Agricultural Biotechnology
  • Opportunity Indicators in a Nutshell
  • Transgenic Seeds & Crops Spearhead Growth in the Agricultural Biotech Market
  • Highlights
  • Significant Benefits of GM Crops Augur Well for Market Growth
  • Biotech Cropland Worldwide - An Overview
  • Developed Regions Lead GM Crop Cultivation, Developing Regions Promise Future Growth
  • Barriers to Expansion of Biotechnology in Agriculture Industry
  • Bt. Cotton: Adoption All Set to Increase Further in the Coming Years
  • Robust R&D Pipeline to Play a Pivotal Role in Adoption of Bt. Cotton
  • Challenges Hindering Wider Adoption of GM Crops
  • Biopesticides: Natural Attributes Spur Global Demand
  • Developed Countries: Leading Consumers of Biopesticides
  • Biopesticides - A Crucial Component for Implementing Integrated Pest Management
  • Explosive Growth in Organic Farming Augurs Well for Biopesticides Market
  • Lack of Familiarity & Negative Perceptions Hinder Uptake of Biopesticides among Farmers
  • Biopesticide Regulations in the US and Europe
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • ADAMA Agricultural Solutions Ltd. (Israel)
  • BASF SE (Germany)
  • Bayer CropScience AG (Germany)
  • Certis USA LLC (USA)
  • Dow AgroSciences, LLC (USA)
  • Mycogen Seeds (USA)
  • DuPont Pioneer (USA)
  • Marrone Bio Innovations, Inc. (USA)
  • Monsanto Company (USA)
  • Performance Plants, Inc. (Canada)
  • Syngenta AG (Switzerland)
  • Valent BioSciences Corporation (USA)
3. MARKET TRENDS & DRIVERS
  • Food Security - An Opportunity Generator
  • Rising Demand for Biofuels: Positive Implications for GM Crops Market
  • Introduction of Bt Cotton and Bt Brinjal Enhance Agricultural Production
  • IRRI Working to Develop Stress-Tolerant Rice Variants
  • Advent of Insect Resistant Crops Fuel Growth for Agriculture Industry
  • Global Reservations Persist in Acknowledging Benefits of GM Crops
  • Integration of Biotechnology and IT Revolutionizes Agriculture Sector
  • Development of New Herbicide-Tolerant Traits Gathers Steam
  • Advanced Farming Techniques for Increasing Agricultural Yields
  • Misuse of Indigenous Resources of Developing Countries: A Cause of Concern
  • Educating Consumers - Need of the Hour
  • Synthetic Biology - A Brief Review
  • Synthetic Biology: Prediction Becoming Reality
  • Biostimulants: Growing Interest in Organic Food to Propel Growth
  • Need for Sustainable Agriculture - Key Growth Driver
  • Lack of Thorough Research Impedes Growth in Biostimulants Market
  • Need for Paradigm Shift in Grower Mindset Regarding Biostimulants
  • The Road Ahead
  • Sales of Non-GMO products to Register Impressive Growth
  • Public-Private Sector Partnerships Gain Importance
  • Protection of Intellectual Property Demands High Attention
  • Challenges Aplenty for Agricultural Biotechnology in Developing Nations
  • Dearth of Competent Leadership
  • Insufficient Financial Support for R&D
  • Lack of Scientific and Technological Infrastructure
  • Insufficient Expertise and Human Resources
  • Safety Issues
  • Ethical Issues
  • Lack of Regulatory Framework
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Agricultural Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Tissue Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Tissue Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Transgenic Crops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Transgenic Crops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 22: World Current & Future Analysis for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Synthetic Biology-enabled Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Synthetic Biology-enabled Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 25: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 27: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 28: USA Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 29: USA Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 30: USA 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 31: USA Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: USA Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 33: USA 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
  • Table 34: Canada Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 35: Canada Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 36: Canada 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 37: Canada Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Canada Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 39: Canada 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 40: Japan Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 41: Japan Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 42: Japan 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 43: Japan Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Japan Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 45: Japan 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
  • Table 46: China Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 47: China Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 48: China 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 49: China Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: China Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 51: China 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 52: Europe Current & Future Analysis for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 53: Europe Historic Review for Agricultural Biotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 54: Europe 15-Year Perspective for Agricultural Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 55: Europe Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 57: Europe 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 58: Europe Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 59: Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 60: Europe 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 61: France Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: France Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 63: France 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 64: France Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 65: France Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 66: France 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 67: Germany Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Germany Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 69: Germany 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 70: Germany Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 71: Germany Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 72: Germany 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
  • Table 73: Italy Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: Italy Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 75: Italy 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 76: Italy Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 77: Italy Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 78: Italy 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 79: UK Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: UK Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 81: UK 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 82: UK Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 83: UK Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 84: UK 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 85: Rest of Europe Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Rest of Europe Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 87: Rest of Europe 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 88: Rest of Europe Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 89: Rest of Europe Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 90: Rest of Europe 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 91: Asia-Pacific Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Asia-Pacific Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 93: Asia-Pacific 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 94: Asia-Pacific Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 95: Asia-Pacific Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 96: Asia-Pacific 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 97: Rest of World Current & Future Analysis for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 98: Rest of World Historic Review for Agricultural Biotechnology by Type - Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 99: Rest of World 15-Year Perspective for Agricultural Biotechnology by Type - Percentage Breakdown of Value Sales for Molecular Diagnostics, Tissue Culture, Vaccines, Genetic Engineering and Other Types for the Years 2012, 2020 & 2027
  • Table 100: Rest of World Current & Future Analysis for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 101: Rest of World Historic Review for Agricultural Biotechnology by Application - Transgenic Crops, Synthetic Biology-enabled Products and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 102: Rest of World 15-Year Perspective for Agricultural Biotechnology by Application - Percentage Breakdown of Value Sales for Transgenic Crops, Synthetic Biology-enabled Products and Other Applications for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 70
Note: Product cover images may vary from those shown
Adroll
adroll